Comprehensive Healthcare Systems, Inc.

Comprehensive Healthcare Systems Inc. develops customized healthcare administrative software solutions. It offers membership cards, disease management, pre-certification, claim processing, and bill payment services. The company also provides licensing and maintenance services. It serves unions and self-insured funds, insurance companies, third party administrators, hospitals, and healthcare consumers, as well as doctors, dentists, and practitioners. The company was founded in 2001 and is headquartered in Edison, New Jersey.

Comprehensive Healthcare Systems, Inc. trades as CMHSF on OTC. The company is classified in Healthcare / Medical - Healthcare Information Services and reports in USD.

The current profile places the business in Medical - Healthcare Information Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $4.19M of revenue and -$2.18M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Comprehensive Healthcare Systems, Inc. can be compared against peers such as AI/ML Innovations Inc., Cellbxhealth PLC, LianBio, TrivarX Limited, NuGen Medical Devices Inc., Nass Valley Gateway Ltd..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $7.06M, beta of 2.27, and return on equity of +35.2%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CMHSF currently shows total debt of $2.67M and beta of 2.27. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.comphealthsys.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.